Background: Nowadays the average age of population is increasing, resulting in a growing proportion of older people in society. Diseases typical of older adults pose a major challenge for modern medicine. These include, among others, neurodegenerative diseases. Aim: To provide a general overview of the most common neurodegenerative diseases, with particular emphasis on substances essential for the proper functioning of the nervous system and diets used to prevent and alleviate the symptoms of neurodegenerative diseases. Materials and methods: This article reviews the publicly available literature from recent years on neurodegenerative diseases, diets used in their treatment and substances essential for the proper functioning of the nervous system. Results: Oxidative stress plays a significant role in the development of nervous system damage in neurodegenerative diseases. Therefore, for the proper functioning of the nervous system, it is essential to provide antioxidant substances in the diet, which mitigate the effects of oxidative stress. Vitamins and polyunsaturated fatty acids are also important in the diet. These nutrients are part of a healthy, balanced diet, which includes the Mediterranean diet. Conclusions: Using a well-balanced diet as a part of healthy lifestyle can prevent neurodegenerative diseases, and if they do occur, slow their progression or help improve the quality of life of those affected. Therefore, diet and a healthy lifestyle are extremely important for healthy aging and the prevention of age-related diseases.
Background: Alzheimer’s disease (AD) is the leading cause of dementia worldwide. Despite advances in modern medicine, effective therapeutic strategies capable of preventing and treating patients suffering from AD are still being actively sought. Growing evidence suggests that the gut microbiota may play a significant role in the development and progression of AD through inflammatory, metabolic, and immune-mediated mechanisms. Aim: This review aims to summarize current evidence regarding the association between the gut microbiome, its metabolites, and Alzheimer’s disease, and to discuss potential therapeutic strategies targeting the gut microbiota in the prevention and management of AD. Materials and Methods: The literature search was conducted using databases such as PubMed and Google Scholar. The following keywords were used: Alzheimer’s disease, gut microbiota, gut microbiome, dysbiosis, gut-brain axis. Results: To date, the majority of findings suggest that modulation of gut microbiota composition through probiotic supplementation may represent a promising approach for developing therapeutic and preventive strategies in Alzheimer’s disease. Probiotics appear effective in stabilizing or reconstructing gut microbial homeostasis, potentially delaying the progression of neurodegenerative pathology. Nevertheless, a review of the literature reveals a deficit of clinical trials evaluating the effects of probiotic supplementation in individuals with AD. Conclusions: To date, prevailing evidence suggests that modulation of gut microbiota composition using probiotics constitutes a promising approach for the development of therapeutic and preventive strategies in Alzheimer’s disease.
Background: Coronary artery disease (CAD) is the leading cause of mortality worldwide. Although established risk factors such as hypertension or dyslipidaemia are well recognized, they do not fully account for the residual cardiovascular risk. Growing evidence suggest that the gut microbiota may play a significant role in development and progression of CAD through inflammatory, metabolic and immune-mediated mechanisms. Aim: This review aims to summarize current evidence on the association between the gut microbiome, its metabolites and CAD, and to discuss potential therapeutic strategies targeting the gut microbiota in CAD prevention and management. Materials and methods: The search was conducted using databases such as PubMed or Google Scholar. Following keywords were used: coronary artery disease, cardiovascular disease, gut microbiota, gut microbiome, dysbiosis, SCFAs, TMAO. Results: Patients with CAD exhibit gut microbiome dysbiosis, characterized by decrease of SCFA-producing bacteria and increase of microorganisms capable of TMAO synthesis. Decreased SCFAs production leads mainly to disrupted intestinal barrier integrity, resulting in leakage of pro-inflammatory LPS. On the other hand, TMAO has been strongly associated with CAD risk factors such as atherosclerosis. Emerging microbiota-targeted interventions like probiotics, prebiotics, symbiotics or fecal microbiota transplant have demonstrated promising results in the management of CAD. Conclusions: Gut microbiota represents an important and modifiable factor in the pathophysiology of CAD. At present, the dietary modifications offer the most accessible and effective strategy of microbiota modification and further research is needed to define the role of microbiome-related therapies.
1 February 2026 in Journal of Education, Health and Sport
Background: Endocrine disrupting chemicals (EDCs) impact human health by modulating endogenous hormones. While linked to metabolic, oncological, and reproductive disorders, literature often focuses narrowly on specific aspects of male health. Objective: To provide a holistic analysis of EDC impact on male health (Homo sapiens) based on literature from 2000–2025, excluding in vitro and animal models. Methods: A three-stage review of PubMed identified 51 records. After rigorous screening, 34 high-quality studies (systematic reviews, meta-analyses, and RCTs) addressing effects on the living male organism were synthesized. Results: EDC impact is multidirectional and highly dependent on exposure windows. The prenatal period is critical for testicular cancer development and adult semen quality. Exposure to BPA, phthalates, and PAHs correlates with increased risk of ADHD and autistic behaviors in boys. Metabolically, PFAS and bisphenols correlate with abdominal obesity and diabetes, showing strong sexual dimorphism. Pathophysiological mechanisms include disruption of the HPG/HPT axes, oxidative stress, and epigenetic modifications. Conclusions: EDCs are a systemic risk factor extending far beyond reproduction. Key research barriers include methodological heterogeneity and the neglect of the "cocktail effect." There is an urgent need for standardized, longitudinal prospective studies starting from the prenatal period to assess real-world anthropogenic impacts.
Introduction: "Pregorexia" is a popular term used to describe restrictive eating behaviors and excessive physical activity during pregnancy aimed at controlling body weight. Although it is not recognized as a formal psychiatric diagnosis, this phenomenon is associated with serious psychosocial and somatic consequences. Aim of the study: This review aims to synthesize current evidence on the psychopathological and neuroendocrine mechanisms of "pregorexia," as well as its impact on fetoplacental homeostasis and the long-term health outcomes of both mother and child. Materials and methods: A literature review was conducted using Google Scholar and PubMed databases to analyze publications concerning the effects of maternal stress, malnutrition, and eating disorders - including anorexia nervosa and pregorexia - on the placenta, the fetus, and the mother. Review of the literature: Chronic caloric restriction leads to disruptions in neuroendocrine axes (such as the HPA and HPT axes) and induces oxidative stress and systemic inflammation. This impairs placental structure and function (including glucose and amino acid transport) and results in intrauterine growth restriction (IUGR). Epigenetic modifications and fetal programming increase the offspring's risk of metabolic disorders (obesity, insulin resistance) and neurodevelopmental conditions (ADHD, autism spectrum disorders) in adult life. In the mother, nutritional deficiencies and stress exacerbate anxiety, postpartum depression, and hinder the mother-infant bonding process. Conclusions: "Pregorexia" represents a significant yet frequently overlooked clinical issue requiring early diagnosis and multidisciplinary management involving obstetric, psychological, psychiatric, and dietary care.
Introduction. Rising global longevity is leading to a significant increase in the proportion of older adults worldwide. Inherent to this aging process are physiological and neurological declines, such as reduced muscle mass, diminished strength, and impaired cognitive functions. As a key driver of cellular energy production, creatine supplementation may represent a promising strategy to mitigate these deficits and preserve functional independence in older adults. Aim of the study. The aim of this review is to synthesize current evidence on the effects of creatine supplementation on physical performance and cognitive function in older adults. Materials and methods. A systematic review was executed across the PubMed and Google Scholar platforms. The following keywords were used: creatine, aging, geriatrics, sarcopenia, muscle strength, bone density, rehabilitation, cognitive function, memory, fall prevention, resistance training. Results. Creatine supplementation improves both physical and mental health in older adults. It aids in the prevention of sarcopenia, the maintenance of muscle mass and strength, may positively influence bone health, and reduces the risk of falls. Additionally, it has a positive impact on cognitive functions, specifically improving memory and mental processing. Conclusions. Creatine should be considered a key part of nutrition for the geriatric population to support healthy aging. Because it helps both the body and the brain, it is an important tool for improving quality of life. Future research should focus on determining the most effective doses for long-term health.